Co-expression of CD69, CD49d, CD279 and CD20 in chronic lymphocytic leukemia cells is a new biomarker of active disease before or under therapy
Not available.
Saved in:
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Ferrata Storti Foundation
2024-09-01
|
| Series: | Haematologica |
| Online Access: | https://haematologica.org/article/view/11765 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1850261796155293696 |
|---|---|
| author | Sarah Cadot Loïc Ysebaert Sébastien Lamy Camille Laurent Anne Quillet-Mary |
| author_facet | Sarah Cadot Loïc Ysebaert Sébastien Lamy Camille Laurent Anne Quillet-Mary |
| author_sort | Sarah Cadot |
| collection | DOAJ |
| description |
Not available.
|
| format | Article |
| id | doaj-art-a35cc62ebfd74f2194b22c29b2f7c193 |
| institution | OA Journals |
| issn | 0390-6078 1592-8721 |
| language | English |
| publishDate | 2024-09-01 |
| publisher | Ferrata Storti Foundation |
| record_format | Article |
| series | Haematologica |
| spelling | doaj-art-a35cc62ebfd74f2194b22c29b2f7c1932025-08-20T01:55:19ZengFerrata Storti FoundationHaematologica0390-60781592-87212024-09-01999110.3324/haematol.2024.285595Co-expression of CD69, CD49d, CD279 and CD20 in chronic lymphocytic leukemia cells is a new biomarker of active disease before or under therapySarah Cadot0Loïc Ysebaert1Sébastien Lamy2Camille Laurent3Anne Quillet-Mary4INSERM UMR1037, CNRS UMR5071, Université Toulouse III-Paul Sabatier, Centre de Recherches en Cancérologie de Toulouse, Toulouse, France; Laboratoire d’Excellence 'TOUCAN-2', ToulouseINSERM UMR1037, CNRS UMR5071, Université Toulouse III-Paul Sabatier, Centre de Recherches en Cancérologie de Toulouse, Toulouse, France; Laboratoire d’Excellence 'TOUCAN-2', Toulouse, France; Institut Universitaire du Cancer-Oncopole de Toulouse, ToulouseTarn Cancer Registry, Claudius Regaud Institute, Institut Universitaire du Cancer-Oncopole de Toulouse, Toulouse, France; CERPOP INSERM UMR1295, Université Toulouse III-Paul Sabatier, ToulouseINSERM UMR1037, CNRS UMR5071, Université Toulouse III-Paul Sabatier, Centre de Recherches en Cancérologie de Toulouse, Toulouse, France; Laboratoire d’Excellence 'TOUCAN-2', Toulouse, France; Institut Universitaire du Cancer-Oncopole de Toulouse, ToulouseINSERM UMR1037, CNRS UMR5071, Université Toulouse III-Paul Sabatier, Centre de Recherches en Cancérologie de Toulouse, Toulouse, France; Laboratoire d’Excellence 'TOUCAN-2', Toulouse Not available. https://haematologica.org/article/view/11765 |
| spellingShingle | Sarah Cadot Loïc Ysebaert Sébastien Lamy Camille Laurent Anne Quillet-Mary Co-expression of CD69, CD49d, CD279 and CD20 in chronic lymphocytic leukemia cells is a new biomarker of active disease before or under therapy Haematologica |
| title | Co-expression of CD69, CD49d, CD279 and CD20 in chronic lymphocytic leukemia cells is a new biomarker of active disease before or under therapy |
| title_full | Co-expression of CD69, CD49d, CD279 and CD20 in chronic lymphocytic leukemia cells is a new biomarker of active disease before or under therapy |
| title_fullStr | Co-expression of CD69, CD49d, CD279 and CD20 in chronic lymphocytic leukemia cells is a new biomarker of active disease before or under therapy |
| title_full_unstemmed | Co-expression of CD69, CD49d, CD279 and CD20 in chronic lymphocytic leukemia cells is a new biomarker of active disease before or under therapy |
| title_short | Co-expression of CD69, CD49d, CD279 and CD20 in chronic lymphocytic leukemia cells is a new biomarker of active disease before or under therapy |
| title_sort | co expression of cd69 cd49d cd279 and cd20 in chronic lymphocytic leukemia cells is a new biomarker of active disease before or under therapy |
| url | https://haematologica.org/article/view/11765 |
| work_keys_str_mv | AT sarahcadot coexpressionofcd69cd49dcd279andcd20inchroniclymphocyticleukemiacellsisanewbiomarkerofactivediseasebeforeorundertherapy AT loicysebaert coexpressionofcd69cd49dcd279andcd20inchroniclymphocyticleukemiacellsisanewbiomarkerofactivediseasebeforeorundertherapy AT sebastienlamy coexpressionofcd69cd49dcd279andcd20inchroniclymphocyticleukemiacellsisanewbiomarkerofactivediseasebeforeorundertherapy AT camillelaurent coexpressionofcd69cd49dcd279andcd20inchroniclymphocyticleukemiacellsisanewbiomarkerofactivediseasebeforeorundertherapy AT annequilletmary coexpressionofcd69cd49dcd279andcd20inchroniclymphocyticleukemiacellsisanewbiomarkerofactivediseasebeforeorundertherapy |